Arkolith/Insider Trading/AKTS

AKTS Insider Trading

Aktis Oncology, Inc. · full profile →Last filing Jul 20, 2026

Filings under AKTS by Akoustis Technologies, Inc. (CIK 0001584754) from Jun 1, 2017 to Jan 29, 2024 belong to a different issuer and are not shown.

Net Selling · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$3.0M
3 insiders
Net Insider Flow
-$3.0M
open market, 180d
Reporting Insiders
3
9 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

72 shown
DateInsiderRoleActionSharesPriceValue
Jul 20, 2026Herrmann KenDirectorOption exercise(M)4K$0.08$280
Jul 20, 2026Herrmann KenDirectorOption exercise(M)1K$1.91$3K
Jul 20, 2026Herrmann KenDirectorSell(S)4K$24.56$86K
Jul 20, 2026Herrmann KenDirectorSell(S)1K$24.56$33K
Jul 20, 2026Herrmann KenDirectorOption exercise(M)4K—$0
Jul 20, 2026Herrmann KenDirectorOption exercise(M)1K—$0
Jul 17, 2026Herrmann KenDirectorOption exercise(M)3K$0.08$245
Jul 17, 2026Herrmann KenDirectorSell(S)3K$25.21$77K
Jul 17, 2026Herrmann KenDirectorOption exercise(M)3K—$0
Jul 8, 2026Ron-Bigger ShulamitChief Operating OfficerOption exercise(M)50K$3.66$183K
Jul 8, 2026Ron-Bigger ShulamitChief Operating OfficerSell(S)16K$27.13$429K
Jul 8, 2026Ron-Bigger ShulamitChief Operating OfficerSell(S)30K$27.94$838K
Jul 8, 2026Ron-Bigger ShulamitChief Operating OfficerSell(S)4K$28.75$121K
Jul 8, 2026Ron-Bigger ShulamitChief Operating OfficerOption exercise(M)50K—$0
Jul 8, 2026Czibere AkosChief Medical OfficerOption exercise(M)50K$4.95$248K
Jul 8, 2026Czibere AkosChief Medical OfficerSell(S)15K$27.13$401K
Jul 8, 2026Czibere AkosChief Medical OfficerSell(S)31K$27.95$862K
Jul 8, 2026Czibere AkosChief Medical OfficerSell(S)4K$28.71$125K
Jul 8, 2026Czibere AkosChief Medical OfficerOption exercise(M)50K—$0
Apr 15, 2026Gormley GlennDirectorGrant(A)38K—$0
Jan 12, 2026Nodelman OlegDirectorBuy(P)2.1M$18.00$37.4M
Jan 12, 2026Nodelman OlegDirectorConversion(C)129K——
Jan 12, 2026Nodelman OlegDirectorConversion(C)203K——
Jan 12, 2026Nodelman OlegDirectorConversion(C)2.3M——
Jan 12, 2026Nodelman OlegDirectorBuy(P)144K$18.00$2.6M
Jan 12, 2026Nodelman OlegDirectorConversion(C)9.9M——
Jan 12, 2026Nodelman OlegDirectorConversion(C)997K——
Jan 12, 2026Nodelman OlegDirectorConversion(C)489K——
Jan 12, 2026Nodelman OlegDirectorConversion(C)2.4M——
Jan 12, 2026Nodelman OlegDirectorConversion(C)965K——
Jan 12, 2026Nodelman OlegDirectorConversion(C)86K——
Jan 12, 2026Nodelman OlegDirectorConversion(C)103K——
Jan 12, 2026Kim Helen SusanDirector, 10% OwnerConversion(C)4.9M——
Jan 12, 2026Kim Helen SusanDirector, 10% OwnerBuy(P)23K$18.00$406K
Jan 12, 2026Kim Helen SusanDirector, 10% OwnerConversion(C)135K——
Jan 12, 2026Kim Helen SusanDirector, 10% OwnerBuy(P)812K$18.00$14.6M
Jan 12, 2026Kim Helen SusanDirector, 10% OwnerConversion(C)14.8M—$0
Jan 12, 2026Kim Helen SusanDirector, 10% OwnerConversion(C)101K—$0
Jan 12, 2026Kim Helen SusanDirector, 10% OwnerConversion(C)3.6M—$0
Jan 12, 2026Kim Helen SusanDirector, 10% OwnerConversion(C)412K—$0
Jan 12, 2026Segal Lloyd MitchellDirectorConversion(C)20K——
Jan 12, 2026Segal Lloyd MitchellDirectorConversion(C)25K—$0
Jan 12, 2026Segal Lloyd MitchellDirectorConversion(C)50K—$0
Jan 12, 2026Vida Ventures II-A, LLC10% OwnerConversion(C)4.9M——
Jan 12, 2026Vida Ventures II-A, LLC10% OwnerBuy(P)23K$18.00$406K
Jan 12, 2026Vida Ventures II-A, LLC10% OwnerConversion(C)135K——
Jan 12, 2026Vida Ventures II-A, LLC10% OwnerBuy(P)812K$18.00$14.6M
Jan 12, 2026Vida Ventures II-A, LLC10% OwnerConversion(C)14.8M—$0
Jan 12, 2026Vida Ventures II-A, LLC10% OwnerConversion(C)412K—$0
Jan 12, 2026Vida Ventures II-A, LLC10% OwnerConversion(C)101K—$0
Jan 12, 2026Vida Ventures II-A, LLC10% OwnerConversion(C)3.6M—$0
Jan 12, 2026Gadicke Ansbert10% OwnerConversion(C)1.3M——
Jan 12, 2026Gadicke Ansbert10% OwnerBuy(P)1.1M$18.00$20.0M
Jan 12, 2026Gadicke Ansbert10% OwnerConversion(C)1.6M——
Jan 12, 2026Gadicke Ansbert10% OwnerConversion(C)5.9M——
Jan 12, 2026Gadicke Ansbert10% OwnerConversion(C)6.0M—$0
Jan 12, 2026Gadicke Ansbert10% OwnerConversion(C)5.0M—$0
Jan 12, 2026Gadicke Ansbert10% OwnerConversion(C)22.5M—$0
Jan 12, 2026MPM Oncology Innovations Fund LP10% OwnerConversion(C)1.6M——
Jan 12, 2026MPM Oncology Innovations Fund LP10% OwnerConversion(C)5.9M——
Jan 12, 2026MPM Oncology Innovations Fund LP10% OwnerConversion(C)1.3M——
Jan 12, 2026MPM Oncology Innovations Fund LP10% OwnerBuy(P)1.1M$18.00$20.0M
Jan 12, 2026MPM Oncology Innovations Fund LP10% OwnerConversion(C)22.5M—$0
Jan 12, 2026MPM Oncology Innovations Fund LP10% OwnerConversion(C)6.0M—$0
Jan 12, 2026MPM Oncology Innovations Fund LP10% OwnerConversion(C)5.0M—$0
Jan 12, 2026Foley ToddDirector, 10% OwnerConversion(C)2.7M——
Jan 12, 2026Foley ToddDirector, 10% OwnerBuy(P)233K$18.00$4.2M
Jan 12, 2026Foley ToddDirector, 10% OwnerConversion(C)597K——
Jan 12, 2026Foley ToddDirector, 10% OwnerConversion(C)717K——
Jan 12, 2026Foley ToddDirector, 10% OwnerConversion(C)2.3M—$0
Jan 12, 2026Foley ToddDirector, 10% OwnerConversion(C)2.7M—$0
Jan 12, 2026Foley ToddDirector, 10% OwnerConversion(C)10.2M—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Issuer: Aktis Oncology, Inc., SEC CIK 0002035832. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under AKTS and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.

Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-15. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).

Keep exploring

Connected pages for AKTS